{"database": "lobbying", "table": "lobbying_activities", "rows": [[1196291, "d82ba2eb-0a4e-4f08-bdae-a7e34dc8565f", "Q4", "THE DUBERSTEIN GROUP INC.", 12675, "PFIZER INC.", 2011, "fourth_quarter", "PHA", "Reimported drugs from Canada - HR 2112, Consolidated and Further Continuing Appropriations Act, 2012.\nCounterfeit drug penalty enforcement act - S 1886, Counterfeit Drug Penalty Enhancement Act of 2011.\nPatent and generic drugs - Congressional investigation re this issue.", "HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR)", 100000, null, 0, 0, "2012-01-19T14:20:47-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1196291"], "units": {}, "query_ms": 0.7627198938280344, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}